Part 11 Compliance Tools On Horizon For Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
FDA has cited two medical device manufacturers for violations of its electronic records/signatures requirements 21 CFR Part 11, which the agency continues to enforce on a discretionary basis
You may also be interested in...
Sulzer Orthopedics Bankruptcy Remains An Option After Appeals Ruling
A federal appeals court ruling against state claims related to Sulzer Orthopedics' Inter-Op hip recall and Natural Knee II implant withdrawals temporarily averts a possible bankruptcy filing by the firm
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.